Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Trending Product / SARS-CoV-2

Anti-NSP1 Polyclonal Antibody

Catalog #:   PVV01001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P0DTD1
Overview

Catalog No.

PVV01001

Species reactivity

SARS-CoV-2 (2019-nCoV)

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant SARS-CoV-2 NSP1 (Met1-Gly180).

Tested applications

ELISA: 1:4000-1:8000, WB: 1:2000-1:8000

Target

Host translation inhibitor nsp1,Leader protein,Non-structural protein 1,nsp1,Replicase polyprotein 1ab,pp1ab,ORF1ab polyprotein

Purification

Purified by antigen affinity column.

Accession

P0DTD1

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with NSP1 antibody (PVV01001) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 22 kDa
    Observed MW: 22 kDa
References

Differential clearance rate of proteins encoded on a self-amplifying mRNA COVID-19 vaccine in muscle and lymph nodes., PMID:40236291

Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanisms., PMID:39932490

MDA5 Is a Major Determinant of Developing Symptoms in Critically Ill COVID-19 Patients., PMID:39460899

T Cell Peptide Prediction, Immune Response, and Host-Pathogen Relationship in Vaccinated and Recovered from Mild COVID-19 Subjects., PMID:39456150

A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications., PMID:38997518

How does a Saccharomyces cerevisiae extract influence the components of isolated rotavirus particles from stool samples collected in a clinical setting from children?, PMID:38946847

Antibody Binding Captures High Energy State of an Antigen: The Case of Nsp1 SARS-CoV-2 as Revealed by Hydrogen-Deuterium Exchange Mass Spectrometry., PMID:38139170

A Novel Rotavirus Reverse Genetics Platform Supports Flexible Insertion of Exogenous Genes and Enables Rapid Development of a High-Throughput Neutralization Assay., PMID:37896813

Comparative whole genome analysis reveals re-emergence of human Wa-like and DS-1-like G3 rotaviruses after Rotarix vaccine introduction in Malawi., PMID:37305707

Intranasal or airborne transmission-mediated delivery of an attenuated SARS-CoV-2 protects Syrian hamsters against new variants., PMID:37296125

The antiviral activity of a small molecule drug targeting the NSP1-ribosome complex against Omicron, especially in elderly patients., PMID:36960047

Targeting viral proteins for restraining SARS-CoV-2: focusing lens on viral proteins beyond spike for discovering new drug targets., PMID:36723288

Active and Passive Immunization of Syrian Hamsters with An Attenuated SARS-CoV-2 Protects against New Variants of Concern., PMID:36380761

Intranasal delivery of a rationally attenuated SARS-CoV-2 is immunogenic and protective in Syrian hamsters., PMID:36357440

Treatment of Sindbis Virus-Infected Neurons with Antibody to E2 Alters Synthesis of Complete and nsP1-Expressing Defective Viral RNAs., PMID:36069441

Structural investigations of proteins encoded by SARS-CoV-2., PMID:36045569

Expression Profile and Localization of SARS-CoV-2 Nonstructural Replicase Proteins in Infected Cells., PMID:35730969

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children., PMID:35618731

SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies., PMID:35587364

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins., PMID:35405107

A Detailed Overview of Immune Escape, Antibody Escape, Partial Vaccine Escape of SARS-CoV-2 and Their Emerging Variants With Escape Mutations., PMID:35222380

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins., PMID:35216036

Anti-SARS-CoV-2 IgG responses are powerful predicting signatures for the outcome of COVID-19 patients., PMID:35116173

Immunogenic and antigenic analysis of recombinant NSP1 and NSP11 of PRRS virus., PMID:35023299

Emerging Mutations in Nsp1 of SARS-CoV-2 and Their Effect on the Structural Stability., PMID:34684233

Replication and single-cycle delivery of SARS-CoV-2 replicons., PMID:34648371

Virus-Like Vesicles Based on Semliki Forest Virus-Containing Rabies Virus Glycoprotein Make a Safe and Efficacious Rabies Vaccine Candidate in a Mouse Model., PMID:34346765

Performance assessment of a multi-epitope chimeric antigen for the serological diagnosis of acute Mayaro fever., PMID:34321560

Antibody landscape against SARS-CoV-2 reveals significant differences between non-structural/accessory and structural proteins., PMID:34242574

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children., PMID:33655259

SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?, PMID:33622224

New-Onset IgG Autoantibodies in Hospitalized Patients with COVID-19., PMID:33532787

Plasmacytoid Dendritic Cells Mediate Control of Ross River Virus Infection via a Type I Interferon-Dependent, MAVS-Independent Mechanism., PMID:33361425

Generation of recombinant rotaviruses encoding a split NanoLuc peptide tag., PMID:33250174

Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus., PMID:32554697

Overwhelming mutations or SNPs of SARS-CoV-2: A point of caution., PMID:32445924

Comparative Sequence Analysis of Historic and Current Porcine Rotavirus C Strains and Their Pathogenesis in 3-Day-Old and 3-Week-Old Piglets., PMID:32395116

Field porcine reproductive and respiratory syndrome viruses (PRRSV) attenuated by codon pair deoptimization (CPD) in NSP1 protected pigs from heterologous challenge., PMID:31928999

Specific recombinant proteins of porcine epidemic diarrhea virus are immunogenic, revealing their potential use as diagnostic markers., PMID:31500721

Mutating chikungunya virus non-structural protein produces potent live-attenuated vaccine candidate., PMID:31015278

Development of an Enzyme-Linked Immunosorbent Assay To Detect Antibodies Targeting Recombinant Envelope Protein 2 of Mayaro Virus., PMID:30787146

Approved drugs screening against the nsP1 capping enzyme of Venezuelan equine encephalitis virus using an immuno-based assay., PMID:30639438

Development of Stable Rotavirus Reporter Expression Systems., PMID:30541830

Development of an ELISA assay for screening inhibitors against divalent metal ion dependent alphavirus capping enzyme., PMID:29958924

Nsp1α of Porcine Reproductive and Respiratory Syndrome Virus Strain BB0907 Impairs the Function of Monocyte-Derived Dendritic Cells via the Release of Soluble CD83., PMID:29793955

Type I interferon suppression-negative and host mRNA nuclear retention-negative mutation in nsp1β confers attenuation of porcine reproductive and respiratory syndrome virus in pigs., PMID:29402432

The Nucleocapsid Protein and Nonstructural Protein 10 of Highly Pathogenic Porcine Reproductive and Respiratory Syndrome Virus Enhance CD83 Production via NF-κB and Sp1 Signaling Pathways., PMID:28659471

Antiviral activity of [1,2,3]triazolo[4,5-d]pyrimidin-7(6H)-ones against chikungunya virus targeting the viral capping nsP1., PMID:28619679

Fingolimod treatment abrogates chikungunya virus-induced arthralgia., PMID:28148838

Comparative Proteomics Reveals Strain-Specific β-TrCP Degradation via Rotavirus NSP1 Hijacking a Host Cullin-3-Rbx1 Complex., PMID:27706223

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-NSP1 Polyclonal Antibody [PVV01001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only